Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.
Hillaire-Buys D, Mousset M, Allouchery M, Azzouz B, Babin M, Bellet F, Béné J, Default A, Durrieu G, Géniaux H, Grandvuillemin A, Gras-Champel V, Jantzem H, Lambert A, Lepelley M, Massy N, Petitpain N, Rocher F, Sanchez-Pena P, Sassier M, Simon C, Triquet L, Valnet-Rabier MB, Veyrac G, Faillie JL, Zenut MC. Hillaire-Buys D, et al. Among authors: grandvuillemin a. Therapie. 2020 Sep-Oct;75(5):471-480. doi: 10.1016/j.therap.2019.08.001. Epub 2019 Oct 28. Therapie. 2020. PMID: 31732241
Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
Gourbil M, Grandvuillemin A, Beyens MN, Massy N, Gras V, D'Amico A, Miremont-Salamé G, Petitpain N; French Network of Regional Pharmacovigilance Centres. Gourbil M, et al. Among authors: grandvuillemin a. Drug Saf. 2014 Apr;37(4):269-82. doi: 10.1007/s40264-014-0149-8. Drug Saf. 2014. PMID: 24634164
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Bénard-Laribière A, et al. Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25. Fundam Clin Pharmacol. 2015. PMID: 24990220
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.
Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, Grandvuillemin A, Mauprivez C, Lapeyre-Mestre M, Montastruc JL; French Association of PharmacoVigilance Centers. Moulis G, et al. Among authors: grandvuillemin a. Eur J Intern Med. 2014 Oct;25(8):777-80. doi: 10.1016/j.ejim.2014.09.006. Epub 2014 Sep 18. Eur J Intern Med. 2014. PMID: 25242516
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
Scanvion Q, Béné J, Gautier S, Grandvuillemin A, Le Beller C, Chenaf C, Etienne N, Brousseau S, Cortot AB, Mortier L, Staumont-Sallé D, Morschhauser F, Forestier A, Groh M, Launay D, Hachulla E, Labalette M, Kahn JE, Lefèvre G. Scanvion Q, et al. Among authors: grandvuillemin a. Oncoimmunology. 2020 Apr 7;9(1):1722022. doi: 10.1080/2162402X.2020.1722022. eCollection 2020. Oncoimmunology. 2020. PMID: 32313716 Free PMC article.
The French pharmacovigilance surveys: A French distinctiveness, a real input.
Abou Taam M, Jacquot B, Ferard C, Thery AC, Mounier C, Grandvuillemin A, Jonville-Béra AP, Perault-Pochat MC; Réseau français des centres régionaux de pharmacovigilance. Abou Taam M, et al. Among authors: grandvuillemin a. Therapie. 2021 Sep-Oct;76(5):441-447. doi: 10.1016/j.therap.2020.05.011. Epub 2020 May 24. Therapie. 2021. PMID: 32553501
49 results